SecBot SecBot

BIOE

Bio Essence Corp
OTC· Pharmaceutical Preparations· Inc. CA· CIK 0001723059 Biotech & Drug Discovery
$0.4200 +0.00 (+0.00%)
Oct 23 4:00 PM ET · prev $0.4200
1 year
+508.7%
from $0.0690 · Oct 27
30 days
+130.8%
from $0.1820
52-week range
$0.0510–0.5170
−19% from high · low Jan 13
Avg volume 20D
10.5K
Oct 7 spike 84.7K
Short interest
2.5K
−52.5%
Days to cover
1.0
at average volume
Insider net
$0
no open-market trades · 12 mo
Filing reports
1
analyzed by SecBot
SecBot read MIXED 1 report · 90 days
Balance 0 bearish · 0 bullish · 1 neutral oldest → newest, height = score
Avg score ·High conf. 1/1
Strongest NEUTRAL Bio Essence Corp. filed an 8-K reporting the election of Thea Zhang and Geoff Fellows as directors by…
All reports →

Price

Daily candles with volume. Pins mark insider trades, rating changes, 13F stakes, reports, catalysts and short-interest jumps.

  • X Apr 30 Short interest falls 36.3% to 5.3K
  • X May 15 Short interest falls 52.5% to 2.5K

Signal stack

Where each data set points today.

  • InsidersNO TRADES

    No open-market buys or sells in 12 months. Recent filings are awards, exercises and tax withholding.

  • Short sellersCOVERING

    Short interest −52.5% to 2.5K shares. 1.0 days to cover.

  • TrendUPTREND

    75% above its 50-day average.

Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
Oct 23, 2026 SEC
Bio Essence Corp. filed an 8-K reporting the election of Thea Zhang and Geoff Fellows as directors by shareholder…
8-K — Impact 2/10
Oct 30, 2024 Insider
Yan Yin sold 143,845 shares
Chief Executive Officer @ $0.5700 ($82.0K)
Oct 29, 2024 Insider
Yan Yin sold 4,000 shares
Chief Executive Officer @ $0.6430 ($2.6K)
Oct 28, 2024 Insider
Yan Yin sold 140,000 shares
Chief Executive Officer @ $2.48 ($347.5K)

Insider ledger

Form 4
$0
open-market buys or sells · 12 mo
DateInsiderTypeValue
Oct 30, 2024
Yan Yin
Chief Executive Officer
SELL$82.0K
Oct 29, 2024
Yan Yin
Chief Executive Officer
SELL$2.6K
Oct 28, 2024
Yan Yin
Chief Executive Officer
SELL$347.5K

Earnings setup

Estimates
PeriodEPS est.Range30D rev.Revenue
Current Q———$0.00
Next Q———$0.00
Current FY———$0.00
Next FY———$0.00

Short side

FINRA· May 15, 2026
2,500
shares short
-52.5%
vs prior settlement
1.0
days to cover

SecBot reports

1 filing · 0 bullish · 0 bearish · 1 neutral
All BIOE filing & press-release reports (1)